1. Home
  2. MAA vs RLAY Comparison

MAA vs RLAY Comparison

Compare MAA & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAA
  • RLAY
  • Stock Information
  • Founded
  • MAA 1977
  • RLAY 2015
  • Country
  • MAA United States
  • RLAY United States
  • Employees
  • MAA N/A
  • RLAY N/A
  • Industry
  • MAA Real Estate Investment Trusts
  • RLAY Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • MAA Real Estate
  • RLAY Health Care
  • Exchange
  • MAA Nasdaq
  • RLAY Nasdaq
  • Market Cap
  • MAA 17.4B
  • RLAY 576.1M
  • IPO Year
  • MAA 1994
  • RLAY 2020
  • Fundamental
  • Price
  • MAA $147.11
  • RLAY $3.38
  • Analyst Decision
  • MAA Buy
  • RLAY Strong Buy
  • Analyst Count
  • MAA 19
  • RLAY 11
  • Target Price
  • MAA $176.79
  • RLAY $18.40
  • AVG Volume (30 Days)
  • MAA 1.0M
  • RLAY 1.6M
  • Earning Date
  • MAA 07-30-2025
  • RLAY 08-05-2025
  • Dividend Yield
  • MAA 4.11%
  • RLAY N/A
  • EPS Growth
  • MAA 0.75
  • RLAY N/A
  • EPS
  • MAA 4.81
  • RLAY N/A
  • Revenue
  • MAA $2,196,688,000.00
  • RLAY $7,679,000.00
  • Revenue This Year
  • MAA $2.37
  • RLAY $14.31
  • Revenue Next Year
  • MAA $3.97
  • RLAY N/A
  • P/E Ratio
  • MAA $30.70
  • RLAY N/A
  • Revenue Growth
  • MAA 1.55
  • RLAY N/A
  • 52 Week Low
  • MAA $137.51
  • RLAY $1.78
  • 52 Week High
  • MAA $173.38
  • RLAY $10.72
  • Technical
  • Relative Strength Index (RSI)
  • MAA 37.37
  • RLAY 54.31
  • Support Level
  • MAA $145.24
  • RLAY $3.10
  • Resistance Level
  • MAA $149.08
  • RLAY $3.37
  • Average True Range (ATR)
  • MAA 2.22
  • RLAY 0.24
  • MACD
  • MAA 0.02
  • RLAY -0.01
  • Stochastic Oscillator
  • MAA 25.39
  • RLAY 51.52

About MAA Mid-America Apartment Communities Inc.

Mid-America Apartment Communities Inc or MAA, is a real estate investment trust engaged in the acquisition, operation, and development of multifamily apartment communities located in the southeastern and southwestern United States. The company operates two reportable segments; Same Store includes communities that the Company has owned and have been stabilized for at least a full 12 months as of the first day of the calendar year and Non-Same Store and Other includes recently acquired communities, communities being developed or in lease-up, communities that have been disposed of or identified for disposition, communities that have experienced a casualty loss and stabilized communities that do not meet the requirements to be Same Store communities.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

Share on Social Networks: